International Headache Registry Study

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 9, 2022

Keywords

ClinConnect Summary

The International Headache Registry Study is looking at different types of headaches, including migraines, tension-type headaches, and conditions related to vertigo (a type of dizziness). Researchers want to learn more about how these headaches affect people of all ages, from children as young as 4 to seniors up to 99. They will collect information on various factors such as genetics, heart conditions, and treatment responses, with the goal of understanding better how these headaches and related disorders can be managed over time.

To participate in this study, individuals must be between the ages of 4 and 99 and have a diagnosed headache condition that fits specific criteria. Participants will need to give their written consent and agree to share their health information. They should be able to track their headaches using a diary and be willing to take part in long-term follow-up visits. This study is currently recruiting participants and aims to help improve the understanding and treatment of headache disorders for everyone involved.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• The following are requirements for entry into the study:
• • 1. Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
• • 2. Male or female participants ages 4 to 99 years, inclusive, at Visit 1.
• • 3. Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches, and patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).
• Exclusion Criteria:
• • 1. Patients who were unable to complete scales such as headache diary.
• • 2. Patients denied or unable to be admitted for long-term follow-up.